SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-17-004278
Filing Date
2017-08-11
Accepted
2017-08-11 16:31:44
Documents
54
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q s107044_10q.htm 10-Q 330281
2 EX-31.01 s107044_ex31-01.htm EX-31.01 8856
3 EX-31.02 s107044_ex31-02.htm EX-31.02 8933
4 EX-32.01 s107044_ex32-01.htm EX-32.01 5871
  Complete submission text file 0001615774-17-004278.txt   2781025

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE tnxp-20170630.xml EX-101.INS 473075
6 XBRL SCHEMA FILE tnxp-20170630.xsd EX-101.SCH 33694
7 XBRL CALCULATION FILE tnxp-20170630_cal.xml EX-101.CAL 37918
8 XBRL DEFINITION FILE tnxp-20170630_def.xml EX-101.DEF 132286
9 XBRL LABEL FILE tnxp-20170630_lab.xml EX-101.LAB 282242
10 XBRL PRESENTATION FILE tnxp-20170630_pre.xml EX-101.PRE 215036
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 171025540
SIC: 2834 Pharmaceutical Preparations